Early-stage rectal cancer: Clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection

Diseases of the Colon and Rectum

Volumn 57, Issue 4, 2014, Pages 449-459

  Patel, Sagar A ^a   Chen, Yu Hui ^b   Hornick, Jason L ^a   Catalano, Paul ^b   Nowak, Jonathan A ^a   Zukerberg, Lawrence R ^c   Bleday, Ronald ^a   Shellito, Paul C ^c   Hong, Theodore S ^c   Mamon, Harvey J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Prognosis; Rectal cancer; Recurrence; Survival

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLONOSCOPY; CONTROLLED STUDY; EARLY CANCER; ENDOSCOPIC SURGERY; FAMILIAL COLON POLYPOSIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCAL EXCISION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PERINEURAL INVASION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PROCTOCOLECTOMY; RADICAL RESECTION; RECTUM CARCINOMA; RECTUM HEMORRHAGE; RECTUM RESECTION; RETROSPECTIVE STUDY; SIGMOIDOSCOPY; TERTIARY CARE CENTER; TUMOR VOLUME; ULCER; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898759581     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e3182a70709     Document Type: Article

References (31)

1. Stamos MJ, Murrell Z. Management of early rectal T1 and T2 cancers. Clin Cancer Res. 2007;13(22 pt 2):6885s-6889s.
2. Blumberg D, Paty PB, Picon AI, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg. 1998;186:574-579.
3. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH; Pathology Review Committee; Cooperative Clinical Investigators. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002;26:350-357.
4. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
5. Sauer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740.
6. Huh JW, Kim CH, Kim HR, Kim YJ. Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable? Surgery. 2011;150:980-984.
7. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245:726-733.
8. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, García- Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000;43:1064-1071.
9. Greenberg JA, Shibata D, Herndon JE 2nd, Steele GD Jr, Mayer R, Bleday R. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum. 2008;51:1185-1191.
10. You YN. Local excision: is it an adequate substitute for radical resection in T1/T2 patients? Semin Radiat Oncol. 2011;21:178-184.
11. Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ, Marijnen CA. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol. 2008;9:494-501.
12. De Graaf EJ, Doornebosch PG, Tollenaar RA, et al. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol. 2009;35:1280-1285.
13. Patel SC, Tovee EB, Langer B. Twenty-five years of experience with radical surgical treatment of carcinoma of the extraperitoneal rectum. Surgery. 1977;82:460-465.
14. Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer. 1983;52:1317-1329.
15. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg. 1985;72:34-37.
16. Fandrich F, Schroder DW, Saliveros E. Long-term survival after curative resection for carcinoma of the rectum. J Am Coll Surg. 1994;178:271-276.
17. Bufalari A, Boselli C, Giustozzi G, Moggi L. Locally advanced rectal cancer: a multivariate analysis of outcome risk factors. J Surg Oncol. 2000;74:2-10.
18. Lee JH, Jang HS, Kim JG, et al. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Ann Surg Oncol. 2012;19:1213-1221.
19. Huh JW, Lee JH, Kim HR. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Arch Surg. 2012;147:366-372.
20. S wedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980-987.
21. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr, Melton LJ 3rd. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer. 1987;60:2318-2324.
22. Isbister WH, Fraser J. Survival following resection for colorectal cancer. A New Zealand national study. Dis Colon Rectum. 1985;28:725-727.
23. Heald RJ, Karanjia ND. Results of radical surgery for rectal cancer. World J Surg. 1992;16:848-857.
24. Chambers WM, Khan U, Gagliano A, Smith RD, Sheffield J, Nicholls RJ. Tumour morphology as a predictor of outcome after local excision of rectal cancer. Br J Surg. 2004;91:457-459.
25. Moskal A, Norat T, Ferrari P, Riboli E. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer. 2007;120:664-671.
26. Ozaka K. Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev. 2007;8:81-88.
27. Tiemersma EW, Wark PA, Ocké MC, et al. Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2003;12:419-425.
28. Chok KS, Law WL. Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg. 2007;31:1485-1490.
29. Sitzler PJ, Seow-Choen F, Ho YH, Leong AP. Lymph node involvement and tumor depth in rectal cancers: an analysis of 805 patients. Dis Colon Rectum. 1997;40:1472-1476.
30. Rasheed S, Bowley DM, Aziz O, et al. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers. Colorectal Dis. 2008;10:231-238.
31. He Y, Van't Veer LJ, Mikolajewska-Hanclich I, et al. PIK3CA mutations predict local recurrences in rectal cancer patients. Clin Cancer Res. 2009;15:6956-6962.